CSTL

Derek J. Maetzold

Known title: Pres. & Chief Exec. OfficerCIK: 0001239501

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 25, 2026

Castle Biosciences Publishes AD Molecular Testing Study, Opens New Lab. Castle Biosciences highlighted a new study that shows a strong need for molecular testing in atopic dermatitis, supporting its AdvanceAD‑Tx product. The company also announced a new laboratory and office facility in Scottsdale, Arizona, expanding its testing capabilities. These developments reinforce the company's focus on precision diagnostics for skin conditions.

this person other insiders at CSTL

Transaction History

CSTL▲ Buy$21K
CSTL▼ Sell$303K
CSTL▼ Sell$96K
CSTL▼ Sell$113K
CSTL▼ Sell$100K
CSTL▼ Sell$7K
CSTL▼ Sell$2K
CSTL▼ Sell$268K
CSTL▼ Sell$85K
CSTL▲ Buy$21K
CSTL▼ Sell$3K
CSTL▲ Buy$30K
CSTL▼ Sell$711
CSTL▼ Sell$83K
CSTL▼ Sell$711
CSTL▼ Sell$380K
CSTL▼ Sell$6K
CSTL▼ Sell$9K
CSTL▼ Sell$7K
CSTL▼ Sell$32K
CSTL▼ Sell$711
CSTL▼ Sell$9K
CSTL▼ Sell$9K
CSTL▼ Sell$9K
CSTL▼ Sell$71K
CSTL▼ Sell$711
CSTL▼ Sell$8K
CSTL▼ Sell$81K
CSTL▼ Sell$69K
CSTL▼ Sell$33K
CSTL▲ Buy$3K
CSTL▼ Sell$8K
CSTL▼ Sell$8K
CSTL▼ Sell$8K
CSTL▼ Sell$15K
CSTL▼ Sell$17K
CSTL▲ Buy$6K
CSTL▼ Sell$78K
CSTL▼ Sell$150K
CSTL▼ Sell$127K
CSTL▼ Sell$259K
CSTL▼ Sell$374K
CSTL▲ Buy$49K
CSTL▼ Sell$104K
CSTL▼ Sell$88K
CSTL▲ Buy$25K
CSTL▼ Sell$128K
CSTL▼ Sell$109K
CSTL▼ Sell$324K
CSTL▼ Sell$195K
CSTL▲ Buy$15K
CSTL▼ Sell$51K
CSTL▼ Sell$60K
CSTL▼ Sell$6K
CSTL▼ Sell$6K
CSTL▼ Sell$6K
CSTL▼ Sell$32K
CSTL▲ Buy$15K
CSTL▼ Sell$144K
CSTL▼ Sell$6K
CSTL▼ Sell$27K
CSTL▼ Sell$251
CSTL▼ Sell$1K
CSTL▼ Sell$1K
CSTL▼ Sell$6K
CSTL▼ Sell$251
CSTL▼ Sell$251
CSTL▼ Sell$251
CSTL▼ Sell$26K
CSTL▼ Sell$13K
CSTL▼ Sell$6K
CSTL▼ Sell$6K
CSTL▲ Buy$1K
CSTL▼ Sell$6K
CSTL▼ Sell$6K
CSTL▼ Sell$31K
CSTL▼ Sell$151K
CSTL▼ Sell$7K
CSTL▼ Sell$7K
CSTL▲ Buy$15K
CSTL▼ Sell$7K
CSTL▼ Sell$33K
CSTL▼ Sell$7K
CSTL▼ Sell$28K
CSTL▼ Sell$24K
CSTL▼ Sell$28K
CSTL▼ Sell$11K
CSTL▼ Sell$6K
CSTL▼ Sell$6K
CSTL▼ Sell$6K
CSTL▲ Buy$1K
CSTL▼ Sell$6K
CSTL▼ Sell$130K
CSTL▼ Sell$6K
CSTL▲ Buy$14K
CSTL▼ Sell$6K
CSTL▼ Sell$6K
CSTL▼ Sell$6K
CSTL▲ Buy$488
CSTL▼ Sell$24K
CSTL▼ Sell$28K
CSTL▼ Sell$18K
CSTL▼ Sell$4K
CSTL▼ Sell$21K
CSTL▼ Sell$4K
CSTL▼ Sell$4K
CSTL▼ Sell$8K
CSTL▲ Buy$1K
CSTL▼ Sell$4K
CSTL▲ Buy$311
CSTL▼ Sell$5K
CSTL▼ Sell$1K
CSTL▼ Sell$6K
CSTL▼ Sell$1K
CSTL▼ Sell$1K
CSTL▼ Sell$3K
CSTL▼ Sell$1K
CSTL▼ Sell$26K
CSTL▼ Sell$117K
CSTL▲ Buy$15K
CSTL▼ Sell$926
CSTL▼ Sell$926
CSTL▼ Sell$4K
CSTL▼ Sell$926
CSTL▼ Sell$926
CSTL▼ Sell$22K
CSTL▼ Sell$4K
CSTL▼ Sell$5K
CSTL▼ Sell$20K
CSTL▼ Sell$5K
CSTL▼ Sell$5K
CSTL▼ Sell$5K
CSTL▼ Sell$14K
CSTL▼ Sell$7K
CSTL▼ Sell$34K
CSTL▼ Sell$7K
CSTL▼ Sell$7K
CSTL▼ Sell$29K
CSTL▲ Buy$1K
CSTL▼ Sell$7K
CSTL▲ Buy$15K
CSTL▼ Sell$7K
CSTL▼ Sell$34K
CSTL▼ Sell$7K
CSTL▼ Sell$156K
CSTL▼ Sell$7K
CSTL▼ Sell$29K
CSTL▼ Sell$7K
CSTL▼ Sell$29K
CSTL▼ Sell$7K
CSTL▼ Sell$35K
CSTL▼ Sell$7K
CSTL▼ Sell$7K
CSTL▼ Sell$14K
CSTL▲ Buy$1K
CSTL▼ Sell$7K
CSTL▼ Sell$17K
CSTL▼ Sell$484K
CSTL▼ Sell$453K
CSTL▼ Sell$3K
CSTL▼ Sell$336K
CSTL▼ Sell$586K
CSTL▼ Sell$7K
CSTL▲ Buy$15K
CSTL▼ Sell$7K
CSTL▼ Sell$7K
CSTL▼ Sell$7K
CSTL▼ Sell$35K
CSTL▼ Sell$30K
CSTL▼ Sell$452K
CSTL▼ Sell$505K
CSTL▲ Buy—
CSTL▼ Sell$525K
CSTL▼ Sell$24K
CSTL▼ Sell$7K
CSTL▼ Sell$128K
CSTL▼ Sell$161K
CSTL▲ Buy$0
CSTL▼ Sell$54K
CSTL▼ Sell$102K
CSTL▼ Sell$33K
CSTL▼ Sell$20K
CSTL▼ Sell$494K
CSTL▼ Sell$717K
CSTL▼ Sell$40K
CSTL▼ Sell$231K
CSTL▲ Buy—
CSTL▼ Sell$504K
CSTL▲ Buy—
CSTL▼ Sell$54K
CSTL▼ Sell$105K
CSTL▼ Sell$171K
CSTL▼ Sell$205K
CSTL▼ Sell$91K
CSTL▼ Sell$85K
CSTL▼ Sell$196K
CSTL▼ Sell$7K
CSTL▼ Sell$30K
CSTL▼ Sell$30K
CSTL▼ Sell$29K

We use analytics to understand how market-wall is used. No personal data is sold.